Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1496077

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1496077

Lateral Flow Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 419 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The global lateral flow assay market, projected to reach US$ 8.9 billion by 2024, is set for substantial expansion with a compound annual growth rate (CAGR) of 6%. By 2031, it is expected to grow to US$ 13 billion. This growth is primarily fueled by rising incidences of sexually transmitted diseases (STDs) and the increasing need for quick and precise diagnostic solutions.

Increasing STD Incidence Driving Market Growth

The Centers for Disease Control and Prevention (CDC) has reported a concerning 30% increase in the number of sexually transmitted diseases. The World Health Organization (WHO) corroborates these findings, citing approximately 374 million new cases of sexually transmitted infections (STIs) in 2020. These infections include chlamydia, gonorrhea, syphilis, and trichomoniasis. Specifically, chlamydia accounted for 129 million cases, gonorrhea for 82 million, syphilis for 7.1 million, and trichomoniasis for 156 million cases. This surge in STD prevalence underscores the critical need for effective diagnostic solutions, thereby propelling the growth of the lateral flow assay market.

Government and Private Sector Efforts Boosting Market Expansion

To combat the rising STD rates, both government and private agencies are intensifying efforts to raise public awareness and promote self-testing policies. WHO estimates suggest that self-testing could help the U.S. achieve the target of diagnosing 90% of people with HIV. As a result, around 41 countries have adopted HIV self-testing protocols. Additionally, there is increasing funding to enhance the reach and effectiveness of HIV testing kits, services, and programs.

Manufacturers like Abbott are playing a pivotal role in supporting developing regions such as Africa. By collaborating with organizations like the African First Ladies Against HIV/AIDS (OAFLA), these companies aim to reduce the spread of HIV, significantly driving the demand for lateral flow assay tests across various regions.

Why Are Lateral Flow Assay Products Gaining Immense Popularity?

"Ease of Use, Cost-Effectiveness, & High Sensitivity of LFA Tests"

Lateral flow assay (LFA) tests have gained widespread acceptance across multiple sectors, including healthcare, animal health, food & feed testing, environmental testing, and plant disease testing. Beyond infectious disease and pregnancy testing, LFA tests are employed in food testing and drug abuse testing. Their ease of use, which reduces the need for hospital visits, has led to strong market penetration for testing seasonal and outbreak indications such as malaria and dengue.

Moreover, the veterinary sector's fast acceptance of LFA tests is contributing to the overall market growth. Lower-middle-income countries are anticipated to see significant adoption growth due to the economical pricing, easy availability, and high sensitivity of LFA tests in infectious disease testing.

Increasing R&D Efforts and Collaborative Initiatives

Research and development efforts are further boosting market growth. Emphasis on R&D for drugs and therapies targeting rare diseases such as malaria and salmonella is creating substantial opportunities for LFA product manufacturers. Collaborative efforts among leading pharmaceutical manufacturers, funding programs, and the presence of reimbursement policies are expected to supplement market expansion.

Challenges Facing the Lateral Flow Assay Market

"High Competition in Market Leading to Sub-Standard Products"

Despite the promising growth, the lateral flow assay market faces several challenges. One major issue is the poor reproducibility of results. LFA tests can yield different results when administered at different times to the same person. Additionally, the simultaneous analysis of multiple markers (multiplexing) remains difficult, and inaccurate sample volume can reduce result precision.

The market also suffers from pricing pressure due to the falling cost of manufacturing and the high volume, low-value nature of LFA kits. Vendors compete based on volume and pricing, leading to the availability of sub-standard products in the market.

Furthermore, LFAs are primarily qualitative tests that detect the presence of diseases. While they can provide semi-quantitative results based on color change, they are not suitable for quantifiable detection and cannot assess the severity of the condition being diagnosed. This limitation restricts their use to primary screening rather than detailed diagnostic applications.

Key Industry Players:

  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Becton, Dickinson & Company
  • PerkinElmer Inc.
  • Siemens Healthineers
  • QIAGEN N.V.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Maternova Inc.
  • Quidel Corporation
  • Healgen Scientific, LLC.
  • Meridian Bioscience Inc.
  • Abcam plc.
  • Access Bio, Inc.
  • Humasis Co. Ltd.
  • DIALUNOX GmbH
  • Detekt Biomedical LLC
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Creative Diagnostics

Market Segmentation

By Product Type:

  • LFA Readers
    • Benchtop Readers
    • Handheld Readers
  • LFA Kits
    • Test Strips
    • Dipsticks
    • Cassettes
    • Lancets

By Application:

  • Sexually Transmitted Diseases
    • Human Deficiency Virus (HIV) Infection
    • Gonorrhoea
    • Syphilis
    • Others
  • Infectious Diseases
    • Mosquito-Borne Diseases
    • Streptococcus Infections
    • Hepatitis Infection
    • Gastrointestinal Infections
    • Respiratory Tract Infections
    • Others
  • Diabetes
  • Pregnancy and Fertility Testing
  • Drug of Abuse Testing

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Supermarkets/Hypermarkets
  • e-Commerce

By Region

  • North America
  • GCC
  • West Asia
  • North Africa
  • South Europe
  • U.K.
  • Rest of Europe
  • Rest of Asia-Pacific
  • Rest of Middle East & Africa

"

Table of Contents

1. Executive Summary

  • 1.1. Global Lateral Flow Assay Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis, by Product Type, US$ Per Unit, 2019 - 2023
  • 3.2. Prominent Factor Affecting Lateral Flow Assay Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Lateral Flow Assay Market Outlook, 2019 - 2031

  • 4.1. Global Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. LFA Readers
        • 4.1.1.1.1. Benchtop Readers
        • 4.1.1.1.2. Handheld Readers
      • 4.1.1.2. LFA Kits
        • 4.1.1.2.1. Test Strips
        • 4.1.1.2.2. Dipsticks
        • 4.1.1.2.3. Cassettes
        • 4.1.1.2.4. Lancets
  • 4.2. Global Lateral Flow Assay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Sexually Transmitted Diseases
        • 4.2.1.1.1. Human Deficiency Virus (HIV) Infection
        • 4.2.1.1.2. Gonorrhoea
        • 4.2.1.1.3. Syphilis
        • 4.2.1.1.4. Others
      • 4.2.1.2. Infectious Diseases
        • 4.2.1.2.1. Mosquito-Borne Diseases
        • 4.2.1.2.2. Streptococcus Infections
        • 4.2.1.2.3. Hepatitis Infection
        • 4.2.1.2.4. Gastrointestinal Infections
        • 4.2.1.2.5. Respiratory Tract Infections
        • 4.2.1.2.6. Others
      • 4.2.1.3. Diabetes
      • 4.2.1.4. Pregnancy and Fertility Testing
      • 4.2.1.5. Drug of Abuse Testing
  • 4.3. Global Lateral Flow Assay Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospital Pharmacies
      • 4.3.1.2. Retail Pharmacies
      • 4.3.1.3. Supermarkets/Hypermarkets
      • 4.3.1.4. e-Commerce
  • 4.4. Global Lateral Flow Assay Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Lateral Flow Assay Market Outlook, 2019 - 2031

  • 5.1. North America Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. LFA Readers
        • 5.1.1.1.1. Benchtop Readers
        • 5.1.1.1.2. Handheld Readers
      • 5.1.1.2. LFA Kits
        • 5.1.1.2.1. Test Strips
        • 5.1.1.2.2. Dipsticks
        • 5.1.1.2.3. Cassettes
        • 5.1.1.2.4. Lancets
  • 5.2. North America Lateral Flow Assay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Sexually Transmitted Diseases
        • 5.2.1.1.1. Human Deficiency Virus (HIV) Infection
        • 5.2.1.1.2. Gonorrhoea
        • 5.2.1.1.3. Syphilis
        • 5.2.1.1.4. Others
      • 5.2.1.2. Infectious Diseases
        • 5.2.1.2.1. Mosquito-Borne Diseases
        • 5.2.1.2.2. Streptococcus Infections
        • 5.2.1.2.3. Hepatitis Infection
        • 5.2.1.2.4. Gastrointestinal Infections
        • 5.2.1.2.5. Respiratory Tract Infections
        • 5.2.1.2.6. Others
      • 5.2.1.3. Diabetes
      • 5.2.1.4. Pregnancy and Fertility Testing
      • 5.2.1.5. Drug of Abuse Testing
  • 5.3. North America Lateral Flow Assay Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospital Pharmacies
      • 5.3.1.2. Retail Pharmacies
      • 5.3.1.3. Supermarkets/Hypermarkets
      • 5.3.1.4. e-Commerce
  • 5.4. North America Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.2. U.S. Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.3. U.S. Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.4. Canada Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.5. Canada Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.6. Canada Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Lateral Flow Assay Market Outlook, 2019 - 2031

  • 6.1. Europe Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. LFA Readers
        • 6.1.1.1.1. Benchtop Readers
        • 6.1.1.1.2. Handheld Readers
      • 6.1.1.2. LFA Kits
        • 6.1.1.2.1. Test Strips
        • 6.1.1.2.2. Dipsticks
        • 6.1.1.2.3. Cassettes
        • 6.1.1.2.4. Lancets
  • 6.2. Europe Lateral Flow Assay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Sexually Transmitted Diseases
        • 6.2.1.1.1. Human Deficiency Virus (HIV) Infection
        • 6.2.1.1.2. Gonorrhoea
        • 6.2.1.1.3. Syphilis
        • 6.2.1.1.4. Others
      • 6.2.1.2. Infectious Diseases
        • 6.2.1.2.1. Mosquito-Borne Diseases
        • 6.2.1.2.2. Streptococcus Infections
        • 6.2.1.2.3. Hepatitis Infection
        • 6.2.1.2.4. Gastrointestinal Infections
        • 6.2.1.2.5. Respiratory Tract Infections
        • 6.2.1.2.6. Others
      • 6.2.1.3. Diabetes
      • 6.2.1.4. Pregnancy and Fertility Testing
      • 6.2.1.5. Drug of Abuse Testing
  • 6.3. Europe Lateral Flow Assay Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospital Pharmacies
      • 6.3.1.2. Retail Pharmacies
      • 6.3.1.3. Supermarkets/Hypermarkets
      • 6.3.1.4. e-Commerce
  • 6.4. Europe Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.2. Germany Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.3. Germany Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.4. U.K. Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.5. U.K. Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.6. U.K. Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.7. France Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.8. France Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.9. France Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.10. Italy Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.11. Italy Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.12. Italy Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.13. Turkey Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.14. Turkey Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.15. Turkey Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.16. Russia Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.17. Russia Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.18. Russia Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.19. Rest of Europe Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.20. Rest of Europe Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.21. Rest of Europe Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Lateral Flow Assay Market Outlook, 2019 - 2031

  • 7.1. Asia Pacific Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. LFA Readers
        • 7.1.1.1.1. Benchtop Readers
        • 7.1.1.1.2. Handheld Readers
      • 7.1.1.2. LFA Kits
        • 7.1.1.2.1. Test Strips
        • 7.1.1.2.2. Dipsticks
        • 7.1.1.2.3. Cassettes
        • 7.1.1.2.4. Lancets
  • 7.2. Asia Pacific Lateral Flow Assay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Sexually Transmitted Diseases
        • 7.2.1.1.1. Human Deficiency Virus (HIV) Infection
        • 7.2.1.1.2. Gonorrhoea
        • 7.2.1.1.3. Syphilis
        • 7.2.1.1.4. Others
      • 7.2.1.2. Infectious Diseases
        • 7.2.1.2.1. Mosquito-Borne Diseases
        • 7.2.1.2.2. Streptococcus Infections
        • 7.2.1.2.3. Hepatitis Infection
        • 7.2.1.2.4. Gastrointestinal Infections
        • 7.2.1.2.5. Respiratory Tract Infections
        • 7.2.1.2.6. Others
      • 7.2.1.3. Diabetes
      • 7.2.1.4. Pregnancy and Fertility Testing
      • 7.2.1.5. Drug of Abuse Testing
  • 7.3. Asia Pacific Lateral Flow Assay Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospital Pharmacies
      • 7.3.1.2. Retail Pharmacies
      • 7.3.1.3. Supermarkets/Hypermarkets
      • 7.3.1.4. e-Commerce
  • 7.4. Asia Pacific Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.2. China Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.3. China Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.4. Japan Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.5. Japan Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.6. Japan Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.7. South Korea Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.8. South Korea Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.9. South Korea Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.10. India Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.11. India Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.12. India Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.13. Southeast Asia Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.14. Southeast Asia Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.15. Southeast Asia Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.16. Rest of Asia Pacific Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.17. Rest of Asia Pacific Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.18. Rest of Asia Pacific Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Lateral Flow Assay Market Outlook, 2019 - 2031

  • 8.1. Latin America Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. LFA Readers
        • 8.1.1.1.1. Benchtop Readers
        • 8.1.1.1.2. Handheld Readers
      • 8.1.1.2. LFA Kits
        • 8.1.1.2.1. Test Strips
        • 8.1.1.2.2. Dipsticks
        • 8.1.1.2.3. Cassettes
        • 8.1.1.2.4. Lancets
  • 8.2. Latin America Lateral Flow Assay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Sexually Transmitted Diseases
        • 8.2.1.1.1. Human Deficiency Virus (HIV) Infection
        • 8.2.1.1.2. Gonorrhoea
        • 8.2.1.1.3. Syphilis
        • 8.2.1.1.4. Others
      • 8.2.1.2. Infectious Diseases
        • 8.2.1.2.1. Mosquito-Borne Diseases
        • 8.2.1.2.2. Streptococcus Infections
        • 8.2.1.2.3. Hepatitis Infection
        • 8.2.1.2.4. Gastrointestinal Infections
        • 8.2.1.2.5. Respiratory Tract Infections
        • 8.2.1.2.6. Others
      • 8.2.1.3. Diabetes
      • 8.2.1.4. Pregnancy and Fertility Testing
      • 8.2.1.5. Drug of Abuse Testing
  • 8.3. Latin America Lateral Flow Assay Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospital Pharmacies
      • 8.3.1.2. Retail Pharmacies
      • 8.3.1.3. Supermarkets/Hypermarkets
      • 8.3.1.4. e-Commerce
  • 8.4. Latin America Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.2. Brazil Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.3. Brazil Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.4. Mexico Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.5. Mexico Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.6. Mexico Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.7. Argentina Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.8. Argentina Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.9. Argentina Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.10. Rest of Latin America Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.11. Rest of Latin America Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.12. Rest of Latin America Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Lateral Flow Assay Market Outlook, 2019 - 2031

  • 9.1. Middle East & Africa Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. LFA Readers
        • 9.1.1.1.1. Benchtop Readers
        • 9.1.1.1.2. Handheld Readers
      • 9.1.1.2. LFA Kits
        • 9.1.1.2.1. Test Strips
        • 9.1.1.2.2. Dipsticks
        • 9.1.1.2.3. Cassettes
        • 9.1.1.2.4. Lancets
  • 9.2. Middle East & Africa Lateral Flow Assay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Sexually Transmitted Diseases
        • 9.2.1.1.1. Human Deficiency Virus (HIV) Infection
        • 9.2.1.1.2. Gonorrhoea
        • 9.2.1.1.3. Syphilis
        • 9.2.1.1.4. Others
      • 9.2.1.2. Infectious Diseases
        • 9.2.1.2.1. Mosquito-Borne Diseases
        • 9.2.1.2.2. Streptococcus Infections
        • 9.2.1.2.3. Hepatitis Infection
        • 9.2.1.2.4. Gastrointestinal Infections
        • 9.2.1.2.5. Respiratory Tract Infections
        • 9.2.1.2.6. Others
      • 9.2.1.3. Diabetes
      • 9.2.1.4. Pregnancy and Fertility Testing
      • 9.2.1.5. Drug of Abuse Testing
  • 9.3. Middle East & Africa Lateral Flow Assay Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospital Pharmacies
      • 9.3.1.2. Retail Pharmacies
      • 9.3.1.3. Supermarkets/Hypermarkets
      • 9.3.1.4. e-Commerce
  • 9.4. Middle East & Africa Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.2. GCC Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.3. GCC Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.4. South Africa Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.5. South Africa Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.6. South Africa Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.7. Egypt Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.8. Egypt Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.9. Egypt Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.10. Nigeria Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.11. Nigeria Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.12. Nigeria Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.13. Rest of Middle East & Africa Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.14. Rest of Middle East & Africa Lateral Flow Assay Market by Application, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.15. Rest of Middle East & Africa Lateral Flow Assay Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Product Type vs Application Heatmap
  • 10.2. Company Market Share Analysis, 2023
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Thermo Fisher Scientific Inc.
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. F. Hoffmann-La Roche
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. Abbott Laboratories
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Becton, Dickinson & Company
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. PerkinElmer Inc.
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Siemens Healthineers
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. QIAGEN N.V.
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. bioMerieux SA
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development
    • 10.4.9. Bio-Rad Laboratories, Inc.
      • 10.4.9.1. Company Overview
      • 10.4.9.2. Product Portfolio
      • 10.4.9.3. Financial Overview
      • 10.4.9.4. Business Strategies and Development
    • 10.4.10. Maternova Inc.
      • 10.4.10.1. Company Overview
      • 10.4.10.2. Product Portfolio
      • 10.4.10.3. Financial Overview
      • 10.4.10.4. Business Strategies and Development
    • 10.4.11. Quidel Corporation
      • 10.4.11.1. Company Overview
      • 10.4.11.2. Product Portfolio
      • 10.4.11.3. Financial Overview
      • 10.4.11.4. Business Strategies and Development
    • 10.4.12. Healgen Scientific, LLC.
      • 10.4.12.1. Company Overview
      • 10.4.12.2. Product Portfolio
      • 10.4.12.3. Financial Overview
      • 10.4.12.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!